Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 21

Trial Status

Other1

Role Distribution

Principal Investigator1
PI Rate100%

Activity Timeline

Clinical Trials (1)

NCT06092606Phase 2Unknown
A Multicenter Clinical Trial on DH001 Tablets in the Prevention of Doxorubicin-induced Cardiotoxicity in Cancer Patients
ArrhythmiaCancerDoxorubicin Adverse Reaction+2 more
PrincipalinvestigatorStart date: 2023-04-04

Research Network

Collaboration Network

42 collaborators·50 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

The First Affilaited Hospital of Wannan Medical College

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Yufu Li

Henan Cancer Hospital

Similar
1 trials

Shared therapeutic areas:

Arrhythmias, CardiacCancerDoxorubicin Adverse Reaction+2 more

Worked with same sponsors:

Monyan Pharmaceutical (Shanghai) Co., Ltd.
Collaborated on 1 trial
Similarity Score54%

Hui Zhou

Hunan Cancer Hospital

Similar
1 trials

Shared therapeutic areas:

Arrhythmias, CardiacCancerDoxorubicin Adverse Reaction+2 more

Worked with same sponsors:

Monyan Pharmaceutical (Shanghai) Co., Ltd.
Collaborated on 1 trial
Similarity Score54%

Hongmei Jing

Peking University Third Hospital

Similar
4 trials

Shared therapeutic areas:

Arrhythmias, CardiacCancerDoxorubicin Adverse Reaction+2 more

Worked with same sponsors:

Monyan Pharmaceutical (Shanghai) Co., Ltd.
Collaborated on 1 trial
Similarity Score54%

Xiaojia Wang

Zhejiang Cancer Hospital

Similar
2 trials

Shared therapeutic areas:

Arrhythmias, CardiacCancerDoxorubicin Adverse Reaction+2 more

Worked with same sponsors:

Monyan Pharmaceutical (Shanghai) Co., Ltd.
Collaborated on 1 trial
Similarity Score54%

Zhenchang Sun

The First Affiliated Hospital of Zhengzhou University

Similar
1 trials

Shared therapeutic areas:

Arrhythmias, CardiacCancerDoxorubicin Adverse Reaction+2 more

Worked with same sponsors:

Monyan Pharmaceutical (Shanghai) Co., Ltd.
Collaborated on 1 trial
Similarity Score54%

Jiwei Liu

The First Affiliated Hospital of Dalian Medical University

Similar
2 trials

Shared therapeutic areas:

Arrhythmias, CardiacCancerDoxorubicin Adverse Reaction+2 more

Worked with same sponsors:

Monyan Pharmaceutical (Shanghai) Co., Ltd.
Collaborated on 1 trial
Similarity Score54%

Andrea Natale, MD

Texas Cardiac Arrhythmia Research Foundation

Related
18 trials

Shared therapeutic areas:

Heart FailureArrhythmias, Cardiac
Similarity Score12%

Brigitte C Widemann, M.D.

National Cancer Institute (NCI)

Related
19 trials

Shared therapeutic areas:

Cancer
Similarity Score6%

loic MONDOLONI

Assistance Publique Hopitaux De Marseille

Related
28 trials

Shared therapeutic areas:

Cancer
Similarity Score6%

Hamid Gourabi, PhD

head of Royan Institute

Related
52 trials

Shared therapeutic areas:

Heart Failure
Similarity Score6%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT06092606Phase 2PrincipalInvestigator

A Multicenter Clinical Trial on DH001 Tablets in the Prevention of Doxorubicin-induced Cardiotoxicity in Cancer Patients

ArrhythmiaCancerDoxorubicin Adverse Reaction+2 more
Unknown

All 1 trials loaded